STC technology inventor
Specialized in innovative cellular therapies Pharmaceutical development expert (Early R&D, QA/QC & development).
Benoît Pinteur (Chief Scientific Officer, PharmD) brings 25 years of experience in the pharma industry with roles at Shering-Plough and Roche, mainly in pharmaceutical development.

From previous collaboration with international teams on autologous cancer immunotherapy (ERC Belgium), he decided to create Brenus Pharma, with the STC Technology, to address previous limitations of immune therapeutics approach.

Benoit was formerly the CEO of BioElpida, a CDMO where he developed expertise in ATMP and GMP manufacturing with a special focus on immunotherapies, cell therapies and vaccines.

• 

  Founder & Chief Scientific Officer in Brenus Pharma

  New generation of precision medicine in oncology with proprietary STC platform designed to generate cancer-vaccines